Is BLU or DIVO a better dividend investment in 2026?

BLU currently yields 13.56% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: BLU offers higher current income.

What is the dividend yield difference between BLU and DIVO?

BLU has a forward dividend yield of 13.56% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 6.94 percentage points.

Home › Compare › BLU vs DIVO

BLU vs DIVO: Dividend Comparison 2026

BLU yields 13.56% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BLU wins by $17.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BLU

● Live price

13.56%

Share price

$14.75

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$48.8K

Annual income

$3,147.85

Full BLU calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — BLU vs DIVO

📍 BLU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BLU	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BLU + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BLU pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLU

Annual income on $10K today (after 15% tax)

$1,152.93/yr

After 10yr DRIP, annual income (after tax)

$2,675.67/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, BLU beats the other by $1,818.47/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLU + DIVO for your $10,000?

BLU: 50%DIVO: 50%

100% DIVO50/50100% BLU

Portfolio after 10yr

$39.9K

Annual income

$2,078.17/yr

Blended yield

5.21%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BLU right now

BLU

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$14.75

+0.0% upside vs current

Range: $14.75 — $14.75

Altman Z

1.3

Piotroski

3/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLU buys

DIVO buys

No recent congressional trades found for BLU or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBLUDIVO

Forward yield	13.56% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$48.8K ✓	$31.0K
Annual income after 10y	$3,147.85 ✓	$1,008.47
Total dividends collected	$22.2K ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BLU vs DIVO ($10,000, DRIP)

Year	BLU Portfolio	BLU Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$12,056	$1,356.39	$11,362	$661.96	+$694.00 → BLU
2	$14,429	$1,528.34	$12,860	$702.91	+$1.6K → BLU
3	$17,148	$1,709.40	$14,504	$743.56	+$2.6K → BLU
4	$20,247	$1,898.67	$16,303	$783.73	+$3.9K → BLU
5	$23,760	$2,095.14	$18,268	$823.31	+$5.5K → BLU
6	$27,720	$2,297.76	$20,408	$862.17	+$7.3K → BLU
7	$32,166	$2,505.44	$22,737	$900.20	+$9.4K → BLU
8	$37,135	$2,717.07	$25,266	$937.31	+$11.9K → BLU
9	$42,666	$2,931.56	$28,008	$973.42	+$14.7K → BLU
10	$48,801	$3,147.85	$30,977	$1,008.47	+$17.8K → BLU

BLU vs DIVO: Complete Analysis 2026

BLU — Stock

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.

Full BLU Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this BLU vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLU vs SCHD BLU vs JEPI BLU vs O BLU vs KO BLU vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.